Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats

Journal of Urology

Volumn 165, Issue 3, 2001, Pages 1004-1009

  Doherty, Paul C ^a,b,c   Bivalacqua, Trinity J ^a,b,c   Champion, Hunter C ^a,b,c   Kadowitz, Philip J ^a,b,c   Meerveld, Beverly Greenwood Van ^a,b,c   Berzetei Gurske, I ^a,b,c   Hellstrom, Wayne J G ^a,b,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Oklahoma Foundation for Digestive Research   (United States)

^c Menlo Park and VIVUS   (United States)

Author keywords

Cyclic GMP cats; Penile erection; Penis; Phosphodiesterase inhibitors

Indexed keywords

CYCLIC GMP; DIPYRIDAMOLE; NITROPRUSSIDE SODIUM; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; VASODILATOR AGENT; ZAPRINAST;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; ERECTILE DYSFUNCTION; MALE; NERVE STIMULATION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL;

EID: 0035131630     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66592-5     Document Type: Article

References (48)

1. Role of nitric oxide in the physiology of erection
2. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission
3. Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue
4. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
5. Nitric oxide: A physiologic mediator of penile erection
6. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis
7. Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit
8. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle
9. A possible neural source of nitric oxide in the rat penis
10. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle
11. Nitric oxide mediates neurogenic relaxation induced in rabbit cavernous smooth muscle by electric field stimulation
12. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neuro-transmission in canine penile erection
13. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
14. Smooth muscle tone regulation in rabbit cavernosal and spongiosal tissue by cyclic AMP- and cyclic GMP-dependent mechanisms
15. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle
16. Cyclic guanosine monophosphate mediates penile erection in the rat
17. Adenylate and guanylate cyclase activity in the penis and aorta of the diabetic rat: An in vitro study
18. Effects of castration and androgen replacement on erectile function in a rabbit model
19. Intracellular mechanism of penile erection in monkeys
20. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney
21. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: Research and clinical implications in erectile dysfunction
22. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases
23. 1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE4)
24. Cyclic nucleotide phosphodiesterase activity in human cavernous smooth muscle and the effects of various selective inhibitors
25. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog
26. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
27. Rat model for the study of penile erection: Pharmacologic and electrical-stimulation parameters
28. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway
29. G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells
30. The influence of castration on pharmacologically induced penile erection in the cat
31. Potassium channel agonists cause penile erection in cats
32. Nitric oxide mediates penile erection in cats
33. Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside
34. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro
35. 1 in patients with erectile dysfunction
36. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
37. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo
38. Intracavernous injection of papaverine for erectile failure
39. Signal transduction in cavernous smooth muscle
40. Multiple cyclic nucleotide phosphodiesterases
41. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
42. Oral, transdermal and transurethral therapies for erectile dysfunction
43. Characterization of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man
44. Intracavernous sodium nitroprusside: Inappropriate impotence treatment
45. Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat
46. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction
47. Oral sildenafil in the treatment of erectile dysfunction
48. Overall cardiovascular profile of sildenafil citrate